Dermatitis During Adjuvant Irradiation for BREAst Cancer:
NCT06483477 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 268
Last updated 2025-01-16
Summary
In the randomized DAI-BREAC trial, a reminder app will be prospectively tested that reminds breast cancer patients four times each day to perform the required skin care. This will likely contribute to the reduction of grade ≥2 radiation dermatitis in these patients. A total of 268 patients will be randomized to receive standard skin care supported by a reminder app (Arm A) or standard skin care alone (Arm B). Stratification will be done using the three factors treatment volume, radiation boost, and at least one risk factor of dermatitis. Secondary aims include pain (radiation fields), patient satisfaction with the reminder app (Arm A only), impact of the app on the use of health technology (Arm A only), and benefit from support by staff members of the treating Department of Radiation Oncology and/or the UKSH academy regarding the use of the app (Arm A only).
Conditions
- Breast Cancer Female
Interventions
- OTHER
-
Standard skin care
From the start of radiotherapy, standard skin care has to be performed by the patient. This may vary at the participating centers. At the site in Lübeck, it includes fatty cream with 2-10% urea (fatty cream alone, if patients do not tolerate urea) and, in case of pruritus, addition of mometasone furoate cream. In case of grade ≥2 moist desquamation or grade ≥3 radiation dermatitis, each day antiseptic agents will be administered for wound cleansing followed by administration of silicon or calcium alginate bandage. This treatment will be continued until moist desquamation radiation disappears and radiation dermatitis improves to grade 2. Fatty cream with 2-10% urea is applied to the irradiated skin four times daily. Mometasone furoate cream: In addition to the fatty cream with 2-10% urea, mometasone furoate cream (solution 0.1%) is applied to the irradiated skin once daily.
- DEVICE
-
Reminder App
In addition to standard skin care, patients are supported by a Reminder App. The purpose of the app is to remind the patients in an intuitive, unobtrusive and supportive way to perform skin care. By default, patients are reminded four times a day, but they will also be able to define a notification schedule that best suits their personal needs. The patients may postpone each required care procedure for up to 2 hours. With each procedure, the patients are guided through the skin care with simple and self-explanatory illustrations. To increase the patients' motivation, they will additionally earn points for regular and punctual performed care procedures. The patients receive a hand-out including instructions how to properly perform skin care, but they can also find an information page within the application that includes similar instructions.
Sponsors & Collaborators
-
University of Southern Denmark
collaborator OTHER -
Medical School Hamburg
collaborator OTHER -
University Hospital Schleswig-Holstein
lead OTHER
Principal Investigators
-
Dirk Rades, MD, FASTRO · Dept. of Radiation Oncology, University of Lubeck, Germany
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-23
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
Countries
- Denmark
- Germany
Study Locations
More Related Trials
-
Scratch Behavior Under Standard of Care
NCT03898427 ·Status: COMPLETED
-
Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities
NCT04929834 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1
-
A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)
NCT04262791 ·Status: TERMINATED ·Phase: PHASE1
-
Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of Age
NCT03684343 ·Status: TERMINATED ·Phase: NA
-
Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis
NCT00843466 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis
NCT00643214 ·Status: COMPLETED ·Phase: NA
-
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
NCT02620293 ·Status: COMPLETED ·Phase: PHASE1
-
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
NCT02108483 ·Status: COMPLETED ·Phase: PHASE1
-
Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis
NCT04955951 ·Status: TERMINATED
-
Safety and Tolerability of the Derma Vax(Trademark) Clinical Intradermal Electroporation System in Healthy Subjects
NCT01324843 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
NCT00645164 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Barrier Products in the Prevention of Incontinence-associated Dermatitis in Hospitalized Elderly
NCT03309059 ·Status: COMPLETED ·Phase: NA
-
Contact Allergy to Rubber Accelerators - a Clinical Study
NCT06042309 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Dexpanthenol in Thermic Erythema
NCT00839462 ·Status: COMPLETED ·Phase: PHASE2
-
Epicutaneous Testing of Cosmetics for Skin Compatibility
NCT03024671 ·Status: RECRUITING ·Phase: NA
-
The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis
NCT05498467 ·Status: COMPLETED ·Phase: PHASE3
-
Utilizing Topical Sodium Hypochlorite to Ameliorate Radiation Dermatitis
NCT04630821 ·Status: TERMINATED ·Phase: NA
-
Preemptive Treatment With XONRID to Reduce Radiation Induced Dermatitis in Head and Neck Cancer Patients
NCT02261181 ·Status: COMPLETED ·Phase: NA
-
The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown
NCT03929224 ·Status: COMPLETED ·Phase: PHASE4
-
Interest of Photographs by Smartphone in Dermatology
NCT03493724 ·Status: UNKNOWN
-
Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Lotion) in the Relief of Sunburn Related Symptoms
NCT01085851 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
NCT01433159 ·Status: TERMINATED ·Phase: PHASE2
-
Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents
NCT02216526 ·Status: COMPLETED ·Phase: NA